Is a 70-year-old patient with mild chronic kidney disease (stage 3a, estimated glomerular filtration rate (eGFR) 52 mL/min/1.73 m²) and otherwise normal pre‑operative labs cleared for surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preoperative Clearance Assessment

This 70-year-old patient is cleared for surgery from a laboratory standpoint, with the important caveat that her Stage 3a chronic kidney disease (eGFR 52 mL/min/1.73 m²) requires specific perioperative renal-protective measures and enhanced monitoring.

Laboratory Analysis

Renal Function Assessment

  • The creatinine of 1.13 mg/dL falls below the critical threshold of 2.0 mg/dL that defines significantly increased perioperative cardiac and renal risk 1
  • The eGFR of 52 mL/min/1.73 m² indicates Stage 3a CKD but remains well above the 30 mL/min/1.73 m² threshold associated with severe perioperative mortality risk 2
  • Preoperative creatinine ≥2.0 mg/dL is the established independent risk factor for cardiac complications after major noncardiac surgery; this patient's value of 1.13 mg/dL does not meet this threshold 1, 3
  • In patients over 70 years undergoing cardiac surgery, creatinine >2.6 mg/dL dramatically increases chronic dialysis risk, but this patient's level is substantially lower 1

Hematologic Parameters

  • The hemoglobin of 14.4 g/dL and hematocrit of 45.0% are well above the 28% threshold associated with increased perioperative ischemia and complications 1
  • All complete blood count parameters fall within normal reference ranges, indicating no anemia-related cardiovascular stress 1

Metabolic and Hepatic Function

  • Glucose of 97 mg/dL is within normal fasting range and does not suggest uncontrolled diabetes 1
  • All liver function tests (AST 21, ALT 17, alkaline phosphatase 65, bilirubin 0.4) are normal 1
  • Electrolytes are within acceptable ranges: sodium 144, potassium 4.9, chloride 108 (minimally elevated), bicarbonate 22 1
  • The albumin of 4.5 g/dL indicates adequate nutritional status 1

Mandatory Perioperative Renal-Protective Measures

Hemodynamic Management

  • Maintain mean arterial pressure (MAP) between 60-70 mmHg intraoperatively, or >70 mmHg if the patient has preexisting hypertension 2
  • Implement goal-directed fluid therapy with stroke volume monitoring to optimize cardiac output and preserve renal perfusion 2

Nephrotoxic Agent Avoidance

  • Eliminate all NSAIDs for postoperative pain control given the reduced eGFR 3, 2
  • Avoid aminoglycosides and minimize or eliminate contrast media exposure 2
  • Adjust all medication dosages according to eGFR to prevent drug accumulation 2

Fluid Management

  • Provide adequate hydration with isotonic crystalloids (lactated Ringer's preferred) to maintain renal perfusion 2, 4
  • Avoid excessive fluid administration that could precipitate pulmonary edema in the setting of reduced renal clearance 4

Enhanced Monitoring Requirements

  • Monitor serum creatinine and urine output closely postoperatively 2
  • Define acute kidney injury as a rise in creatinine of ≥0.5 mg/dL or ≥25% from baseline within 48 hours 2
  • Document preoperative troponin and repeat at 24-48 hours postoperatively for intermediate- and high-risk patients 1

Risk Stratification Context

  • This patient has 2-3 perioperative AKI risk factors: age >56 years, female sex, and eGFR <60 mL/min/1.73 m² 2
  • Patients with fewer than three risk factors have substantially lower AKI risk (hazard ratio <46) compared to those with six or more factors 2
  • The European Society of Cardiology identifies eGFR <60 mL/min/1.73 m² as correlating with major adverse cardiovascular events, warranting heightened vigilance 1, 2

Common Pitfalls to Avoid

  • Do not rely solely on serum creatinine; the eGFR provides superior risk assessment by incorporating age, sex, and body surface area 1, 3
  • Do not discontinue ACE inhibitors or ARBs if prescribed for heart failure or diabetic kidney disease, as small creatinine elevations are not an indication for cessation 1, 2
  • Do not proceed without calculating and documenting the eGFR, as serum creatinine alone misses up to 25% of patients with significantly reduced kidney function 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Perioperative Management for Patients with Reduced Kidney Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Preoperative Management of Patients with Multiple Metabolic Abnormalities

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Risks of TURP in Patients with Elevated Serum Creatinine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the sensitivity and specificity of estimated glomerular filtration rate (eGFR) for detecting chronic kidney disease (CKD) stage 3 or higher (eGFR < 60 mL/min/1.73 m²)?
What is the management approach for a patient with impaired renal function, as indicated by an abnormal estimated Glomerular Filtration Rate (eGFR) and normal creatinine levels?
What is the best management approach for a patient with stage 3b chronic kidney disease, characterized by an eGFR of 39, elevated BUN, and an ACR of 100?
What is the preferred ratio for detecting and monitoring kidney disease, albumin to creatinine (ACR) ratio or protein to creatinine (PCR) ratio?
What is the next step in managing a 60‑year‑old woman with type 2 diabetes, diabetic neuropathy, hypertension, estimated glomerular filtration rate 73 mL/min/1.73 m², whose HbA1c increased from 6.9 % to 7.6 % despite Jardiance (empagliflozin) 10 mg daily and Mounjaro (tirzepatide) 15 mg subcutaneously weekly?
What is the anion gap and how is it calculated?
When should platelet transfusion be administered in a patient with active bleeding?
Is Floranex indicated for the treatment of hypertension?
Is fasting required for thyroid function tests (TSH, free T4, free T3) and lipid panel?
What is the recommended treatment for acute pulmonary embolism?
When is spironolactone contraindicated (e.g., hyperkalaemia, estimated glomerular filtration rate < 30 mL/min/1.73 m², anuria, primary adrenal insufficiency, pregnancy especially first trimester, lactation, concurrent potassium‑sparing diuretics or angiotensin‑converting enzyme inhibitor/angiotensin receptor blocker therapy, severe hepatic failure with marked ascites)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.